Glatiramer Acetate Injection, Solution
Product Images NDC 11797-765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 11797-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Italfarmaco Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg Container Label (Glatiramer 01)

20 mg Container Label (Glatiramer 01)
Packaging label for Glatiramer Acetate Injection, 20 mg/mL, a subcutaneous injection in solution form. The label indicates 10 single-dose pre-filled syringes per package. The labeler is Italfarmaco SpA, with distribution by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions and dosage details.*
FDA Label Image

20 mg Container Label (Glatiramer 02)

20 mg Container Label (Glatiramer 02)
Packaging label for Glatiramer Acetate Injection 40 mg/mL solution for subcutaneous injection. The label indicates a package containing 12 single-dose pre-filled syringes. It is manufactured by Italfarmaco S.P.A. and distributed by Zydus Pharmaceuticals (USA) Inc. Dosage instructions note injection three times a week. The label includes NDC 11797-765-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.